Fenwick, Covington Build $750M Sale Of Pharmaceutical Biz
Global biopharmaceutical company Incyte, advised by Covington & Burling LLP, on Tuesday announced plans to buy clinical-stage drug discovery company Escient Pharmaceuticals, led by Fenwick & West LLP, for $750 million....To view the full article, register now.
Already a subscriber? Click here to view full article